In this conversation, we explore the dynamic interplay between public funding and private investment in shaping the next wave of biotechnology breakthroughs and safeguarding regional technology sovereignty. We’ll examine how government agencies fund high-risk, high-reward early-stage research, why America and China have staked their claims in biotechnology leadership, and what Europe must do to forge its own independent capabilities. The discussion will also highlight the critical role of the private sector—from strategic venture investments in sequencing and diagnostics to innovative startup ventures—and the policy frameworks necessary to sustain a vibrant, self-reliant bioinnovation ecosystem.

This session explores the powerful alliance of space and defense organizations driving the future of off-world biotechnology. Participants will delve into cutting-edge research designed to support life on the Moon and Mars, from resource-efficient manufacturing and regenerative life-support systems to the development of resilient biological tools for extreme environments. By addressing the technical and logistical challenges of long-term space habitation, this discussion highlights how breakthroughs in synthetic biology, high-risk research programs, and cross-agency collaboration can redefine our interplanetary ambitions and accelerate humanity’s progress beyond Earth.